Newron reports striking one - year interim efficacy results from its Phase II clinical trial evaluatin

The Newron Pharmaceuticals has announced a significant increase in the effectiveness of its experimental treatment for schizophrenia. Here's what you need to know about the latest results from its clinical trial and how it could be used to treat the condition.

Source: pharmiweb.com
Published on 2023-02-16